Literature DB >> 6419564

Progressive thrombosis of brain arteriovenous malformations after embolization with isobutyl 2-cyanoacrylate.

F Viñuela, A J Fox, G Debrun, C G Drake, S J Peerless, J P Girvin.   

Abstract

Embolization of brain arteriovenous malformations (AVMs) with isobutyl 2-cyanoacrylate (IBCA) is an alternative to surgical treatment when dealing with large AVMs with multiple arterial feeders. The deposition of IBCA in the nidus of the AVM may produce an active and progressive thrombosis that may lead to complete occlusion of the nidus and/or to progressive thrombosis of the draining veins. Four clinical examples of progressive thrombosis after IBCA embolization are demonstrated, including two cases in which late follow-up angiography showed complete obliteration of a partly embolized AVM.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6419564      PMCID： PMC8334169     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  11 in total

1.  Cerebral arteriovenous malformations.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

2.  Therapeutic management of cerebral arteriovenous malformations. Present role of interventional neuroradiology.

Authors:  F Viñuela; G Duckwiler; R Jahan; Y Murayama
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

3.  Can induction of systemic hypotension help prevent nidus rupture complicating arteriovenous malformation embolization?: analysis of underlying mechanism achieved using a theoretical model.

Authors:  T F Massoud; G J Hademenos; W L Young; E Gao; J Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

4.  N-butyl-2-cyanoacrylate for embolisation of carotid aneurysm.

Authors:  M M Teng; C C Chen; J F Lirng; S S Chen; L S Lee; T Chang
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

5.  Endovascular treatment of cerebral arteriovenous malformations.

Authors:  P Lasjaunias; C Manelfe; K Terbrugge; L Lopez Ibor
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

6.  Combined neuroradiological and neurosurgical treatment of intracerebral arteriovenous malformations.

Authors:  D Adelt; H Brückmann; W Krenkel; W Hacke; H Zeumer
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

Review 7.  The histotoxicity of cyanoacrylates. A selective review.

Authors:  H V Vinters; K A Galil; M J Lundie; J C Kaufmann
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

8.  Bleeding complications after endovascular therapy of cerebral arteriovenous malformations.

Authors:  J O Heidenreich; S Hartlieb; R Stendel; T A Pietilä; P Schlattmann; K-J Wolf; A M Schilling
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

9.  Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits.

Authors:  Robert M Starke; Ricardo J Komotar; Marc L Otten; David K Hahn; Laura E Fischer; Brian Y Hwang; Matthew C Garrett; Robert R Sciacca; Michael B Sisti; Robert A Solomon; Sean D Lavine; E Sander Connolly; Philip M Meyers
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

10.  Disappearance of cerebral arteriovenous malformations after partial endovascular embolisation: four cases with follow-up.

Authors:  M Cellerini; S Mangiafico; G Villa; F Ammannati; G P Giordano
Journal:  Neuroradiology       Date:  2003-11-11       Impact factor: 2.804
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.